Bendamustine Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-102

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bendamustine (NDC 71288-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ben0e 0004 01)

Chemical structure of Bendamustine HCl, showing its molecular configuration with chlorine, nitrogen, carbon, hydrogen, and oxygen atoms arranged in the depicted pattern.*

FDA Label Image

Figure 1 (Ben0e 0004 02)

A line graph titled 'Progression-Free Survival' showing survival distribution function over time in months. It compares study treatments including Bendamustine HCl and Chlorambucil, with survival rates decreasing over time on the x-axis for each treatment group.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 25 mg Vial Label (Ben0e 0004 03)

Label for Bendamustine HCl Injection, USP, 25 mg per vial, lyophilized powder for solution. It is a single-dose vial for intravenous infusion only, requiring reconstitution and dilution. The label includes usage instructions, storage conditions, and manufacturer details for Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 25 mg Carton (Ben0e 0004 04)

Package label for Bendamustine HCl for Injection, USP, 25 mg per vial, lyophilized powder for intravenous infusion. The label indicates a single-dose vial with instructions to discard the unused portion. It features warnings about it being a cytotoxic agent requiring dilution and infusion preparation. The labeler is Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 100 mg Vial Label (Ben0e 0004 05)

Bendamustine HCl for Injection, USP 100 mg per vial single-dose vial label for intravenous infusion, manufactured by Meitheal Pharmaceuticals Inc. The lyophilized powder requires reconstitution and dilution prior to use. Label includes dosage information, preservative-free status, and storage instructions between 15° and 30°C, protected from light.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 100 mg Carton (Ben0e 0004 06)

Bendamustine 100 mg per vial injection powder label, lyophilized for intravenous use. The packaging indicates a single-dose vial with the active ingredient Bendamustine HCl for injection, USP. It is labeled as a cytotoxic agent, manufactured by Meitheal Pharmaceuticals Inc., with instructions for reconstitution and dilution before use. The label includes dosage information, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.